Solution

Run full M&A due diligence at the speed of the deal

Banking M&A teams, corporate development and PE sponsors use Mercurium to compress due diligence from 12-week war-rooms to a few days of structured analysis — driven by our AI Adaptive Q&A that auto-answers hundreds of diligence questions directly from the data room, with citations kept and audit trail preserved.

10×
Faster deal diligence vs. traditional war-room
The Pain Today

Deal timelines collapse. Diligence doesn't. Something has to give — usually quality.

M&A due diligence today is a war-room of analysts reading documents, copying data into spreadsheets, and chasing counterparties. When a deal sprints, something breaks:

  • Data room depth. 600-page SPAs, thousands of underlying contracts, SoFs, financial statements in local GAAP.
  • Target deep dive. UBO chain across 5 jurisdictions, sanctions across 6 regimes, PEPs on the board, adverse media in local press.
  • Regulatory exposure. Competition filings, FCA approvals, CFIUS triggers — all on different clocks.
  • Audit-ready output. The IC needs a defensible memo. The regulator needs a paper trail. You need both, yesterday.
How Mercurium Solves It

Every analyst becomes a whole diligence team — without losing rigour

Drop the full data room in Mercurium. Our document intelligence layer parses every contract, statement and certificate into a structured, queryable format. Then our AI Adaptive M&A Questionnaire runs hundreds of deal-specific questions — EBITDA, working capital, MAC triggers, conditions precedent, UBO chains, regulatory exposure — and auto-answers each one from the data room, with a citation back to the exact document and paragraph.

Your analysts validate, your counsel defends, your investment committee decides. WorkflowAI orchestrates every step into an audit-ready trail your IC and regulator can inspect end-to-end.

Data room ingestion

Drop the full VDR. Mercurium classifies, validates and indexes every document — contracts, statements, certificates, resolutions — into a queryable workspace.

AI Adaptive M&A Questionnaire

Hundreds of deal-specific questions — EBITDA, MAC triggers, CP waivers, UBO chains, regulatory exposure — run automatically and adapt to the deal type (share sale, asset purchase, merger, LBO).

Auto-answered from the data room

Every question is answered directly from uploaded documents with a citation to the exact page and paragraph. No analyst re-types what the SPA already says.

600+ page SPA parsing

Every clause, definition, condition precedent, MAC trigger and earn-out formula extracted with citations to the exact paragraph.

UBO chain resolution

Follows ownership through trusts, SPVs, nominees across 80+ jurisdictions. Every beneficial owner surfaced with evidence.

Target screening at scale

Sanctions, PEP, corporate registries, adverse media in 100+ languages — run on the target and every key person simultaneously.

Financial coherence checks

Cross-validates audited statements against management accounts, bank statements, tax filings and debt schedules. Flags inconsistencies automatically.

Audit-ready IC pack

Every finding, every Q&A, every citation, every reviewer note exported as a single defensible pack for the IC and counsel.

Live Platform UI

See the actual product

These are real Mercurium screens. Hover to straighten — book a demo to drive them with your own data.

AI Adaptive M&A Questionnaire

Deal-specific questions answered directly from the data room — with citations back to the source document.

Live UI · click-disabled preview
M&A Adaptive Q&A
Every question auto-answered from the data room · citations kept · rolling audit trail
84% · 42 of 50 questions
Share purchase Asset purchase Reverse merger LBO
Detected from SPA p.3 · "Sale and Purchase of 100% of the Shares"
Q · Financial What was the target's adjusted EBITDA for FY24?
£ 8.4M
Audited FY24 Statements · p.47 · auto-extracted
Q · Legal Any Material Adverse Change (MAC) trigger in the SPA?
Yes — §6.3
SPA §6.3 · earnings drop >15% YoY triggers right to withdraw
Q · Structure UBO chain through the Luxembourg holding company?
Chen Family Trust · 68%
3 layers · RCS LU + Jersey FSC · resolved automatically
Q · Regulatory Does the deal trigger CFIUS review in the United States?
Agent researching…
Checking FY24 10-K Exhibit 21 + target jurisdictions
9 documents linked to this section
SPA v7 · Audited accounts (3 yrs) · Debt schedules · Key contracts (6) · CP waivers
Auto-validated

Data room ingestion

The full VDR classified, validated and indexed the moment it lands.

Live UI · click-disabled preview
Data Room · Atlas Capital LP
Auto-structured · 47 docs across 5 folders · Last activity 2 min ago
100% complete
Subscription Agreement — signed.pdf
17.4 MB · S. Chen · 12 min ago
Validated
Side Letter — fee waiver.pdf
2.1 MB · S. Chen · 12 min ago
Validated
Passport — S. Chen.jpg
1.8 MB · S. Chen · 14 min ago
OCR · MRZ
Bank Statements — Q1 2026.xlsx
540 KB · S. Chen · 18 min ago
Needs review
Source of Funds Declaration.pdf
320 KB · S. Chen · 22 min ago
Validated

600+ page SPA understood

Every clause, every citation, every cross-reference — mapped.

Live UI · click-disabled preview
Subscription Agreement — Atlas Capital LP.pdf
42 pages · 17.4 MB · Analysed 12s ago
98% confidence
SUBSCRIPTION AGREEMENT
Atlas Capital Partners Fund IV, L.P.
This Subscription Agreement (the "Agreement") is entered into as of 15 March 2026 by and between Atlas Capital Partners GP, LLC (the "General Partner") and the undersigned subscriber ("Subscriber").
The Subscriber hereby agrees to subscribe for limited partnership interests in the aggregate amount of USD 25,000,000 ("Subscription Amount") on the terms set forth herein.
Drawdowns shall occur in tranches of up to 25% of the Subscription Amount per calendar quarter, with the first drawdown scheduled for 30 April 2026.
The Fund's investment manager, Atlas Capital Management Ltd, is authorised and regulated by the FCA under reference 712389.

Target + UBO screening

One panel covers the target, the sellers, the management team and the UBOs.

Live UI · click-disabled preview
Background Checks
Real-time screening across 222M+ entities · OFAC · UN · EU · PEP · Adverse Media
4 sources running
Person
Sarah J. Chen · UBO · 27%
Company
Atlas Capital Partners GP, LLC
Sanctions Screening
No matches across OFAC SDN, UN Consolidated, EU Restrictive, UK HMT
820ms
PEP Match — Family Member
Spouse: David Chen · Senator (US, NY · 2019–) · review recommended
1.2s
Adverse Media · 100+ languages
12 articles reviewed · 0 negative · 1 positive (industry award)
3.4s
Corporate Registries
UBO confirmed in 3 jurisdictions · UK Companies House · DE Handelsregister · LU RCS
2.1s

Full diligence workflow

Ingestion → analysis → Q&A → screening → IC memo — orchestrated, versioned, audit-ready.

Live UI · click-disabled preview
Investor Onboarding · v3
Validated 247 runs · 24h p50 · 3.4 min
Document Upload
PDF · Email · API
Trigger
Document Intelligence
Structure · Entities · Tables
98% accuracy
Auto-Classify
112 doc types
KlassifAI
Background Checks
222M companies · OFAC · UN
Person & Company
Translator
100+ languages
GDPR-resident
Compliance Report
PDF + audit log
Auto-generated
Outcome

Win the deal. Defend the memo. Keep the regulator happy.

M&A teams on Mercurium close diligence 10× faster with more coverage, not less. Investment committees get structured memos where every answer cites the source document and page. Regulators get a versioned, exportable audit trail. Competing on speed no longer means cutting corners — it means your analysts focus on judgement while Mercurium handles the extraction.

10×
Faster diligence cycle
600+
Page docs parsed per target
222M+
Entity records screened

Compress your next deal diligence from weeks to days

Bring us a live data room under NDA. We'll show you the full Mercurium output on the target.

Book a Demo
{# Privacy-first page-view beacon. Sends only the path — no cookies, no localStorage, no query string. Skipped on staff/consultant + on the ingest + on admin/Newsroom paths. The server hashes IP+UA with a daily-rotating salt so daily uniques work without cross-day tracking. #}